As Covid-19 pressures mount, political newcomer Stephen Hahn struggles to protect an FDA under siege
With almost no institutional knowledge behind him, FDA experts worry Hahn is flying blind, leaving the agency flailing amid the Covid-19 pandemic.
Read The Story